Literature DB >> 15240576

Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15240576     DOI： 10.1210/jc.2003-031138

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  20 in total

1.  Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society.

Authors:  Ee Mun Lim; Peter Pullan
Journal:  Clin Biochem Rev       Date:  2005-05

2.  First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group.

Authors:  A Colao; E Martino; P Cappabianca; R Cozzi; M Scanarini; E Ghigo
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

3.  The manifesto A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) study group one year later: what to keep and what to amend?

Authors:  A Colao; E Ghigo
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

Review 4.  Update on the medical management of pituitary adenomas.

Authors:  Cheryl A Pickett
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

5.  Acromegaly without imaging evidence of pituitary adenoma.

Authors:  Russell R Lonser; Bogdan A Kindzelski; Gautam U Mehta; John A Jane; Edward H Oldfield
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

6.  Comparison of two immunoassays in the determination of IGF-I levels and its correlation with oral glucose tolerance test (OGTT) and with clinical symptoms in acromegalic patients.

Authors:  Laura Boero; Marcos Manavela; Karina Danilowicz; Analia Alfieri; Maria Carolina Ballarino; Alberto Chervin; Natalia García-Basavilbaso; Mariela Glerean; Mirtha Guitelman; Monica Graciela Loto; Jose Alberto Nahmías; Amelia Susana Rogozinski; Marisa Servidio; Nicolas Marcelo Vitale; Débora Katz; Patricia Fainstein Day; Graciela Stalldecker; Maria Susana Mallea-Gil
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

7.  Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study.

Authors:  Davide Locatelli; Pierlorenzo Veiceschi; Paolo Castelnuovo; Necmettin Tanriover; Olcay Evliyaoglu; Huseyin Canaz; Doga Ugurlar; Nurperi Gazioglu
Journal:  Childs Nerv Syst       Date:  2019-05-11       Impact factor: 1.475

8.  Advances in the Diagnosis, Treatment, and Molecular Genetics of Pituitary Adenomas in Childhood.

Authors:  Margaret F Keil; Constantine A Stratakis
Journal:  US Endocrinol       Date:  2009-02-01

9.  Efficacy of long-term lanreotide treatment in patients with acromegaly.

Authors:  Yoel Toledano; Liat Rot; Yona Greenman; Sophia Orlovsky; Yulia Pauker; David Olchovsky; Achia Eliash; Orit Bardicef; Ofa Makhoul; Gloria Tsvetov; Michal Gershinsky; Odile Cohen-Ouaqnine; Rosane Ness-Abramof; Zaina Adnan; Jacob Ilany; Hadassah Guttmann; Mazal Sapir; Carlos Benbassat; Ilan Shimon
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 10.  Management of acromegaly in Latin America: expert panel recommendations.

Authors:  Ariel Barkan; Marcello D Bronstein; Oscar D Bruno; Alejandro Cob; Ana Laura Espinosa-de-los-Monteros; Monica R Gadelha; Gloria Garavito; Mirtha Guitelman; Ruth Mangupli; Moisés Mercado; Lesly Portocarrero; Michael Sheppard
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.